CAMP logo

CAMP4 Therapeutics (CAMP) Free Cash Flow

Annual FCF

-$44.83 M
NaN%

December 1, 2023


Summary


Performance

CAMP Free Cash Flow Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherCAMPcash flowmetrics:

Quarterly FCF

-$34.45 M
NaN%

September 1, 2024


Summary


Performance

CAMP Quarterly FCF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherCAMPcash flowmetrics:

TTM FCF

-$34.45 M
NaN%

September 1, 2024


Summary


Performance

CAMP TTM FCF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherCAMPcash flowmetrics:

Free Cash Flow Formula

FCF = Cash From Operations − CAPEX

CAMP Free Cash Flow Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-5.3%-752.9%-1001.8%
3 y3 years-360.2%-202.6%+33.7%
5 y5 years-220.1%-1953.3%-300.0%

CAMP Free Cash Flow Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-360.2%at low-752.9%at low-1001.8%+33.7%
5 y5-year-220.1%at low-593.0%at low-272.7%+33.7%
alltimeall time-176.6%at low-219.7%at low-143.9%+33.7%

CAMP4 Therapeutics Free Cash Flow History

DateAnnualQuarterlyTTM
Sep 2024
-
-$34.45 M(+5.0%)
-$34.45 M(-4.1%)
Dec 2023
-$44.83 M(+5.3%)
-
-
Sep 2023
-
-$32.81 M(-721.7%)
-$35.93 M(+1049.2%)
Aug 2023
-
$5.28 M(-206.9%)
-$3.13 M(-84.2%)
May 2023
-
-$4.94 M(+70.5%)
-$19.79 M(-41.8%)
Feb 2023
-
-$2.90 M(+409.1%)
-$34.03 M(-18.2%)
Dec 2022
-$42.57 M(+143.0%)
-
-
Nov 2022
-
-$569.00 K(-95.0%)
-$41.62 M(-19.9%)
Aug 2022
-
-$11.39 M(-40.6%)
-$51.96 M(+54.3%)
May 2022
-
-$19.18 M(+82.9%)
-$33.68 M(+92.3%)
Feb 2022
-$17.52 M(-201.7%)
-$10.49 M(-3.9%)
-$17.52 M(+238.8%)
Nov 2021
-
-$10.91 M(-258.2%)
-$5.17 M(-140.6%)
Aug 2021
-
$6.90 M(-328.8%)
$12.73 M(+15.4%)
May 2021
-
-$3.02 M(-262.2%)
$11.04 M(-36.0%)
Feb 2021
$17.23 M(-276.6%)
$1.86 M(-73.4%)
$17.23 M(-13.6%)
Nov 2020
-
$6.99 M(+34.4%)
$19.95 M(+105.1%)
Aug 2020
-
$5.20 M(+63.6%)
$9.72 M(+147.6%)
May 2020
-
$3.18 M(-30.5%)
$3.93 M(-140.3%)
Feb 2020
-$9.76 M(-126.1%)
$4.58 M(-241.5%)
-$9.76 M(-39.8%)
Nov 2019
-
-$3.23 M(+444.4%)
-$16.20 M(+236.0%)
Aug 2019
-
-$594.00 K(-94.3%)
-$4.82 M(+146.5%)
May 2019
-
-$10.51 M(+462.4%)
-$1.96 M(-105.2%)
Feb 2019
$37.34 M(-36.2%)
-$1.87 M(-122.9%)
$37.34 M(-17.0%)
Nov 2018
-
$8.15 M(+258.5%)
$45.00 M(-21.5%)
Aug 2018
-
$2.27 M(-92.1%)
$57.32 M(-27.0%)
May 2018
-
$28.79 M(+396.9%)
$78.52 M(+34.1%)
Feb 2018
$58.55 M(+228.3%)
$5.79 M(-71.7%)
$58.55 M(+3.4%)
Nov 2017
-
$20.46 M(-12.8%)
$56.62 M(+64.9%)
Aug 2017
-
$23.47 M(+165.8%)
$34.34 M(+72.0%)
May 2017
-
$8.83 M(+128.9%)
$19.96 M(+11.9%)
Feb 2017
$17.83 M(-58.6%)
$3.86 M(-312.9%)
$17.83 M(-21.0%)
Nov 2016
-
-$1.81 M(-119.9%)
$22.58 M(-30.9%)
Aug 2016
-
$9.09 M(+35.6%)
$32.69 M(-5.9%)
May 2016
-
$6.70 M(-22.1%)
$34.72 M(-19.4%)
Feb 2016
$43.08 M(+103.1%)
$8.60 M(+3.7%)
$43.08 M(+10.1%)
Nov 2015
-
$8.30 M(-25.4%)
$39.12 M(+12.8%)
Aug 2015
-
$11.12 M(-26.2%)
$34.70 M(+14.3%)
May 2015
-
$15.06 M(+224.6%)
$30.35 M(+43.1%)
Feb 2015
$21.21 M(+2.5%)
$4.64 M(+20.0%)
$21.21 M(+10.3%)
Nov 2014
-
$3.87 M(-42.9%)
$19.22 M(-5.8%)
Aug 2014
-
$6.78 M(+14.4%)
$20.41 M(-3.8%)
May 2014
-
$5.92 M(+123.2%)
$21.23 M(+2.6%)
Feb 2014
$20.68 M(+40.3%)
$2.65 M(-47.6%)
$20.68 M(-11.4%)
Nov 2013
-
$5.06 M(-33.3%)
$23.35 M(+9.0%)
Aug 2013
-
$7.59 M(+41.1%)
$21.43 M(+23.4%)
May 2013
-
$5.38 M(+1.2%)
$17.36 M(+17.8%)
Feb 2013
$14.74 M(+29.8%)
$5.32 M(+69.4%)
$14.74 M(+5.6%)
Nov 2012
-
$3.14 M(-11.0%)
$13.96 M(+10.5%)
Aug 2012
-
$3.53 M(+27.8%)
$12.64 M(+5.1%)
May 2012
-
$2.76 M(-39.2%)
$12.03 M(+6.0%)
Feb 2012
$11.36 M(-3026.8%)
$4.54 M(+149.9%)
$11.36 M(+74.5%)
Nov 2011
-
$1.82 M(-37.8%)
$6.51 M(+23.1%)
Aug 2011
-
$2.92 M(+40.0%)
$5.29 M(+98.6%)
May 2011
-
$2.08 M(-772.3%)
$2.66 M(-786.1%)
Feb 2011
-$388.00 K(-125.4%)
-$310.00 K(-152.0%)
-$388.00 K(-81.4%)
Nov 2010
-
$596.00 K(+104.1%)
-$2.08 M(-2.7%)
Aug 2010
-
$292.00 K(-130.2%)
-$2.14 M(-904.5%)
May 2010
-
-$966.00 K(-51.8%)
$266.00 K(-82.6%)
Feb 2010
$1.53 M(-88.2%)
-$2.00 M(-472.0%)
$1.53 M(-89.0%)
Nov 2009
-
$539.00 K(-80.0%)
$13.86 M(-12.1%)
Aug 2009
-
$2.70 M(+808.4%)
$15.77 M(+35.6%)
May 2009
-
$297.00 K(-97.1%)
$11.63 M(-10.1%)
Feb 2009
$12.93 M(-556.0%)
$10.33 M(+321.9%)
$12.93 M(+155.5%)
Nov 2008
-
$2.45 M(-269.3%)
$5.06 M(+1379.5%)
Aug 2008
-
-$1.45 M(-190.4%)
$342.00 K(-133.0%)
May 2008
-
$1.60 M(-35.0%)
-$1.04 M(-63.4%)
Feb 2008
-$2.83 M
$2.46 M(-208.3%)
-$2.83 M(+189.3%)
DateAnnualQuarterlyTTM
Nov 2007
-
-$2.27 M(-19.6%)
-$980.00 K(-108.0%)
Aug 2007
-
-$2.83 M(+1319.6%)
$12.28 M(+25.7%)
May 2007
-
-$199.00 K(-104.6%)
$9.77 M(-29.7%)
Feb 2007
$13.89 M(-30.8%)
$4.31 M(-60.8%)
$13.89 M(-17.6%)
Nov 2006
-
$10.99 M(-306.0%)
$16.86 M(+8.4%)
Aug 2006
-
-$5.34 M(-236.0%)
$15.55 M(-23.3%)
May 2006
-
$3.92 M(-46.1%)
$20.27 M(+0.9%)
Feb 2006
$20.08 M(+97.3%)
$7.28 M(-24.9%)
$20.08 M(+19.2%)
Nov 2005
-
$9.69 M(-1652.7%)
$16.85 M(+91.3%)
Aug 2005
-
-$624.00 K(-116.7%)
$8.81 M(-19.4%)
May 2005
-
$3.74 M(-7.5%)
$10.93 M(+7.4%)
Feb 2005
$10.18 M(+323.9%)
$4.04 M(+145.4%)
$10.18 M(+166.4%)
Nov 2004
-
$1.65 M(+10.0%)
$3.82 M(-19.5%)
Aug 2004
-
$1.50 M(-49.8%)
$4.75 M(-10.2%)
May 2004
-
$2.99 M(-229.2%)
$5.29 M(+120.2%)
Feb 2004
$2.40 M(-37.0%)
-$2.31 M(-189.8%)
$2.40 M(-979.5%)
Nov 2003
-
$2.58 M(+26.4%)
-$273.00 K(-129.5%)
Aug 2003
-
$2.04 M(+1958.6%)
$926.00 K(-69.3%)
May 2003
-
$99.00 K(-102.0%)
$3.01 M(-20.9%)
Feb 2003
$3.81 M(-64.7%)
-$4.99 M(-232.1%)
$3.81 M(-69.2%)
Nov 2002
-
$3.77 M(-8.5%)
$12.38 M(+16.9%)
Aug 2002
-
$4.13 M(+360.9%)
$10.59 M(+13.5%)
May 2002
-
$895.00 K(-75.0%)
$9.33 M(-13.5%)
Feb 2002
$10.78 M(+239.8%)
$3.58 M(+80.3%)
$10.78 M(-12.2%)
Nov 2001
-
$1.99 M(-30.6%)
$12.28 M(+55.4%)
Aug 2001
-
$2.86 M(+21.9%)
$7.91 M(+27.9%)
May 2001
-
$2.35 M(-53.8%)
$6.18 M(+94.9%)
Feb 2001
$3.17 M(-169.8%)
$5.09 M(-312.8%)
$3.17 M(-191.8%)
Nov 2000
-
-$2.39 M(-310.0%)
-$3.46 M(+85.2%)
Aug 2000
-
$1.14 M(-271.9%)
-$1.87 M(-334.4%)
May 2000
-
-$662.00 K(-57.1%)
$796.00 K(-117.5%)
Feb 2000
-$4.54 M(-198.4%)
-$1.54 M(+92.8%)
-$4.54 M(+253.2%)
Nov 1999
-
-$800.00 K(-121.1%)
-$1.29 M(-190.9%)
Aug 1999
-
$3.80 M(-163.3%)
$1.41 M(-161.9%)
May 1999
-
-$6.00 M(-450.1%)
-$2.29 M(-149.5%)
Feb 1999
$4.61 M(+2207.0%)
$1.71 M(-9.8%)
$4.61 M(+28.2%)
Nov 1998
-
$1.90 M(+1800.0%)
$3.60 M(+24.1%)
Aug 1998
-
$100.00 K(-88.9%)
$2.90 M(+107.1%)
May 1998
-
$900.00 K(+28.6%)
$1.40 M(+600.0%)
Feb 1998
$200.00 K(-102.3%)
$700.00 K(-41.7%)
$200.00 K(0.0%)
Nov 1997
-
$1.20 M(-185.7%)
$200.00 K(-106.5%)
Aug 1997
-
-$1.40 M(+366.7%)
-$3.10 M(-24.4%)
May 1997
-
-$300.00 K(-142.9%)
-$4.10 M(-52.9%)
Feb 1997
-$8.70 M(-226.1%)
$700.00 K(-133.3%)
-$8.70 M(+16.0%)
Nov 1996
-
-$2.10 M(-12.5%)
-$7.50 M(+66.7%)
Aug 1996
-
-$2.40 M(-51.0%)
-$4.50 M(-336.8%)
May 1996
-
-$4.90 M(-357.9%)
$1.90 M(-72.5%)
Feb 1996
$6.90 M(+1625.0%)
$1.90 M(+111.1%)
$6.90 M(+46.8%)
Nov 1995
-
$900.00 K(-77.5%)
$4.70 M(-4.1%)
Aug 1995
-
$4.00 M(+3900.0%)
$4.90 M(+600.0%)
May 1995
-
$100.00 K(-133.3%)
$700.00 K(+75.0%)
Feb 1995
$400.00 K(-114.3%)
-$300.00 K(-127.3%)
$400.00 K(-42.9%)
Nov 1994
-
$1.10 M(-650.0%)
$700.00 K(-275.0%)
Aug 1994
-
-$200.00 K(0.0%)
-$400.00 K(+100.0%)
May 1994
-
-$200.00 K(-150.0%)
-$200.00 K(-71.4%)
Feb 1994
-$2.80 M(+300.0%)
-
-
Feb 1993
-$700.00 K(-240.0%)
$400.00 K(-126.7%)
-$700.00 K(-36.4%)
Nov 1992
-
-$1.50 M(-287.5%)
-$1.10 M(-375.0%)
Aug 1992
-
$800.00 K(-300.0%)
$400.00 K(-166.7%)
May 1992
-
-$400.00 K(+100.0%)
-$600.00 K(-700.0%)
Feb 1992
$500.00 K(-600.0%)
-
-
Aug 1991
-
-$200.00 K(-50.0%)
$100.00 K(-200.0%)
May 1991
-
-$400.00 K(-144.4%)
-$100.00 K(0.0%)
Feb 1991
-$100.00 K(-50.0%)
$900.00 K(-550.0%)
-$100.00 K(-90.0%)
Nov 1990
-
-$200.00 K(-50.0%)
-$1.00 M(+25.0%)
Aug 1990
-
-$400.00 K(0.0%)
-$800.00 K(+100.0%)
May 1990
-
-$400.00 K
-$400.00 K
Feb 1990
-$200.00 K
-
-

FAQ

  • What is CAMP4 Therapeutics annual free cash flow?
  • What is the all time high annual FCF for CAMP4 Therapeutics?
  • What is CAMP4 Therapeutics annual FCF year-on-year change?
  • What is CAMP4 Therapeutics quarterly free cash flow?
  • What is the all time high quarterly FCF for CAMP4 Therapeutics?
  • What is CAMP4 Therapeutics quarterly FCF year-on-year change?
  • What is CAMP4 Therapeutics TTM free cash flow?
  • What is the all time high TTM FCF for CAMP4 Therapeutics?
  • What is CAMP4 Therapeutics TTM FCF year-on-year change?

What is CAMP4 Therapeutics annual free cash flow?

The current annual FCF of CAMP is -$44.83 M

What is the all time high annual FCF for CAMP4 Therapeutics?

CAMP4 Therapeutics all-time high annual free cash flow is $58.55 M

What is CAMP4 Therapeutics annual FCF year-on-year change?

Over the past year, CAMP annual free cash flow has changed by -$2.27 M (-5.32%)

What is CAMP4 Therapeutics quarterly free cash flow?

The current quarterly FCF of CAMP is -$34.45 M

What is the all time high quarterly FCF for CAMP4 Therapeutics?

CAMP4 Therapeutics all-time high quarterly free cash flow is $28.79 M

What is CAMP4 Therapeutics quarterly FCF year-on-year change?

Over the past year, CAMP quarterly free cash flow has changed by -$39.73 M (-752.87%)

What is CAMP4 Therapeutics TTM free cash flow?

The current TTM FCF of CAMP is -$34.45 M

What is the all time high TTM FCF for CAMP4 Therapeutics?

CAMP4 Therapeutics all-time high TTM free cash flow is $78.52 M

What is CAMP4 Therapeutics TTM FCF year-on-year change?

Over the past year, CAMP TTM free cash flow has changed by -$31.32 M (-1001.76%)